Salarius Pharmaceuticals, Inc.·4

Feb 22, 4:16 PM ET

Lammers Paul 4

4 · Salarius Pharmaceuticals, Inc. · Filed Feb 22, 2024

Insider Transaction Report

Form 4
Period: 2024-02-20
Lammers Paul
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-20+20,50020,500 total
    Exercise: $0.57From: 2025-02-20Exp: 2034-02-19Common Stock (20,500 underlying)

Documents

1 file
  • 4
    wk-form4_1708636513.xmlPrimary

    FORM 4